https://www.ndtvprofit.com/research-reports/vijaya-diagnostic-q4-results-review-non-covid-patient-footfall-sturdy-icici-securities?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
With higher contribution from radiology, B2C focus, it commands best-in-industry Ebitda margin, which we believe would continue.